| Overall (N=61) |
|
|---|---|
| Age at implantation (y) | |
| Mean (SD) | 62.9 (16.1) |
| Median [Min, Max] | 67.0 [26.0, 88.0] |
| Sex | |
| Male | 39 (63.9%) |
| Female | 22 (36.1%) |
| Implanted side | |
| Right | 34 (55.7%) |
| Left | 27 (44.3%) |
| CI ear hearing loss degree | |
| Moderate (41-55 dB) | 0 (0%) |
| Moderate to Severe (56-70 dB) | 7 (11.5%) |
| Severe (71-90 dB) | 28 (45.9%) |
| Profound (>91 dB) | 26 (42.6%) |
| Contralateral ear hearing loss degree | |
| Moderate (41-55 dB) | 4 (6.6%) |
| Moderate to Severe (56-70 dB) | 11 (18.0%) |
| Severe (71-90 dB) | 34 (55.7%) |
| Profound (>91 dB) | 12 (19.7%) |
| Type of implant | |
| Advanced Bionics ULTRA 3D Midscale | 5 (8.2%) |
| Advanced Bionics ULTRA 3D SlimJ | 6 (9.8%) |
| MEDel Flex 28 Synchrony | 2 (3.3%) |
| Nucleus Cochlear CI522 | 32 (52.5%) |
| Nucleus Cochlear CI622 | 8 (13.1%) |
| Nucleus Cochlear CI632 | 2 (3.3%) |
| Oticon Medical Zti EVO | 6 (9.8%) |
| No. of days between baseline and T1 | |
| Mean (SD) | 147 (90.3) |
| Median [Min, Max] | 110 [66.0, 441] |
| Missing | 10 (16.4%) |
| No. of days between baseline and T2 | |
| Mean (SD) | 449 (91.1) |
| Median [Min, Max] | 416 [327, 806] |
| Missing | 21 (34.4%) |